Decision/Risk Analysis · Brisbane, CA · Founded 2014 · Privately Held (backing)
Developer of a multi-omics platform designed to detect cancer at an early stage through a routine blood draw. Freenome is based in Brisbane, CA and was founded in 2014. It is valued at about $2.2 billion as of Oct 2026, set by institutional fund marks. It has raised $1.4 billion across 3 recorded rounds; the latest was a $240 million pipe round in Dec 2025.
PMV mark · valuation
$2.2B
Oct 2026
Priced at
—
Total raised
$1.4B
Last round
PIPE
Dec 2025
Cap table — not yet on record
Freenome's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.